Femoral Head Prostheses Market Research, 2033
The global femoral head prostheses market was valued at $1.0 billion in 2023, and is projected to reach $1.8 billion by 2033, growing at a CAGR of 5.6% from 2024 to 2033. An increase in the prevalence of orthopedic disorders, surge in the number of surgical procedures is expected to drive the market growth
Market Introduction and Definition
Femoral head prostheses refer to artificial devices specifically designed to replace the femoral head, which is the spherical upper part of the femur (thigh bone) that fits into the hip socket to form the hip joint. These prostheses are primarily used in hip replacement surgeries to restore function and relieve pain in patients with damaged or diseased hip joints. These prostheses are designed to restore the natural movement and function of the hip joint by providing a new, durable, and smooth articulating surface. Furthermore, the increase in the prevalence of orthopedic diseases and other chronic bone disease conditions where the surgery is suggested contribute to the growth of market. The increase in number of incidences of road accidents and rise in number of accident surgeries boost the growth of market. The increase in the road accidents are responsible for hip injury, thereby driving the femoral head prostheses market growth.
Key Takeaways
The femoral head prostheses market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($Million) for the projected period 2024-2033.
More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major femoral head prostheses industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The market for femoral head prostheses is significantly influenced by the rise in the prevalence of orthopedic diseases such as rheumatoid arthritis, bone sarcoma, and osteoarthritis. The hip replacement is a major surgical procedure generally recommended for severe hip pain and hip damage. In addition, an increase in the prevalence of bone and joint cancer contributes in the femoral head prostheses market forecast. The bone sarcoma is responsible for bone and joint damage. The increasing geriatric population drives the growth of the market. The elderly people are more susceptible for orthopedic diseases and bone joints problems. Thus, increase in geriatric population indicates the rise in prevalence of chronic diseases. The elderly people have lower ability to replenish the bone, which leads to bone fractures.
In addition, elderly people are prone to frequent falls due to poor balance, physical illness, medications, deteriorating vision, and environmental hazards. Lack of protective mechanisms, such as use of the hands to break a fall and lack of coordination contribute to the increased incidence of fractures in the elderly. Thus, the rise in the geriatric population boosts the femoral head prostheses market opportunity. The increase in number of R&D activities for the development of advanced hip replacement procedures drives the growth of market. The technological assistance such as navigation software and robotic tools for the hip replacement procedures further contributes in the growth of market.
Patent Analysis, 2015-2024
Although the femoral head prostheses market size growth has been more rapid in recent years, the industry can draw on the patents filed by various companies across various countries. For instance, patents filed by China dominated the same with a 28.7% share, the U.S. holds a share of about 20% and the Patent Cooperation Treaty (PCT) holds a share of about 11.3%.
Market Segmentation
The femoral head prostheses market size is segmented by material, end user, and region. Depending on the material, it is classified into metal-on-metal, metal-on-polyethylene, ceramic-on-metal, and others. Based on end users, the market is categorized into hospitals, orthopedic clinics, and ambulatory surgical centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America accounted for a major femoral head prostheses market share owing to the presence of several major players, availability of advanced healthcare facilities; and high healthcare infrastructure expenditure by the government organizations in the region which drive the growth of the market.?Moreover, this is attributed to the rise in incidences of chronic diseases, and the strong presence of key market players in the region.
Asia-Pacific femoral head prostheses market share is estimated to grow with the highest CAGR during the forecast period, owing to enhancements in healthcare facilities, increase in incidences of hip injury, growth in geriatric population and high population base. In addition, this region offers lucrative opportunities for the femoral head prostheses market key players, owing to a rising awareness of advanced medical technologies. Companies are focusing on this region to expand their market presence.
Industry Trends
Innovations in the development of new materials, such as ceramic, highly cross-linked polyethylene, and advanced metal alloys, have improved the durability and biocompatibility of femoral head prostheses
Minimally invasive surgical techniques reduce hospital stays and accelerate patient recovery, making hip replacement surgeries more attractive.
Competitive Landscape
The major players operating in the femoral head prostheses market are Johnson & Johnson, Smith & Nephew PLC, Zimmer Biomet Holdings Inc., Gruppo Bioimpianti s.r.l., Corin Group PLC, Medacta International, Exactech Inc., Altimed JSC, Amplitude SAS, and Elite Surgical Private Limited.
Recent Developments in the Femoral Head Prostheses Industry
- In August 2023, Smith+Nephew announced the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty in India. Compared with traditional solutions, dual mobility implants have a small diameter femoral head that locks into a larger polyethylene insert increasing stability, reducing dislocation risk, and offering improved range of motion.
- In November 2021, a zirconium-niobium alloy femoral head, designed and developed by Suzhou Minimally Invasive Orthopedics (Group) Co., Ltd. (MicroPort?Orthopedics) , was given access by the National Medical Products Administration (NMPA) of China to enter the ‘Green Path’, the special approval procedure for innovative medical devices.
Key Sources Referred
- National Center for Biotechnology Information
- World Health Organization (WHO)
- National Library of Medicine
- The United States Food and Drug Administration
- U.S. Department of Health & Human Services
- Centers for Disease Control and Prevention
- Australian Institute of Health and Welfare
- Johns Hopkins Medicine
- National Centre for Disease Control (NCDC)
- Australian Government Department of Health and Aged Care?
- Government of Canada's Health and Wellness?
- Ministry of Health and Family Welfare (MoHFW) ?
- National Health Mission (NHM) ?
- Ayushman Bharat - Health and Wellness Centers (AB-HWCs) ?
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the femoral head prostheses market analysis from 2024 to 2033 to identify the prevailing femoral head prostheses market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the femoral head prostheses market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global femoral head prostheses market trends, key players, market segments, application areas, and market growth strategies.
Femoral Head Prostheses Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 1.8 Billion |
 Growth Rate | CAGR of 5.6% |
 Forecast period | 2024 - 2033 |
 Report Pages | 280 |
 By Material |
|
 By End Users |
|
 By Region |
|
 Key Market Players | Exactech Inc., Medacta International, Zimmer Biomet Holdings Inc., Gruppo Bioimpianti s.r.l., Altimed JSC, Smith & Nephew PLC, Corin Group PLC, Johnson & Johnson, Elite Surgical Private Limited, Amplitude SAS |
Asia-Pacific is the fastest growing regional market for Femoral Head Prostheses
The major players operating in the femoral head prostheses market are Johnson & Johnson, Smith & Nephew PLC, Zimmer Biomet Holdings Inc., Gruppo Bioimpianti s.r.l., Corin Group PLC, Medacta International, Exactech Inc., Altimed JSC, Amplitude SAS, and Elite Surgical Private Limited.
The femoral head prostheses market was valued at $1,042.96 million in 2023 and is estimated to reach $1,805.29 million by 2033, exhibiting a CAGR of 5.6% from 2024 to 2033.
North America is the largest regional market for Femoral Head Prostheses
Hospitals is the leading end user of Femoral Head Prostheses Market.
The market for femoral head prostheses is significantly influenced by the rise in the prevalence of orthopedic diseases such as rheumatoid arthritis, bone sarcoma, and osteoarthritis.
Loading Table Of Content...
